Cargando…

Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain–Barré Syndrome

BACKGROUND AND OBJECTIVE: Intravenous immunoglobulin (IVIg) at a standard dosage is the treatment of choice for Guillain–Barré syndrome. The pharmacokinetics, however, is highly variable between patients, and a rapid clearance of IVIg is associated with poor recovery. We aimed to develop a model to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fokkink, Willem Jan R., van Tilburg, Sander J., de Winter, Brenda C. M., Sassen, Sebastiaan D. T., van Doorn, Pieter A., Koch, Birgit C. P., Jacobs, Bart C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439991/ https://www.ncbi.nlm.nih.gov/pubmed/35781631 http://dx.doi.org/10.1007/s40262-022-01136-z

Ejemplares similares

Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study
por: Verboon, Christine, et al.
Publicado: (2021)

IVIg‐induced plasmablasts in patients with Guillain‐Barré syndrome
por: Brem, Maarten D., et al.
Publicado: (2018)

Determination of pain and response to methylprednisolone in Guillain-Barré syndrome
por: Ruts, Liselotte, et al.
Publicado: (2007)

IVIG Treatment and Prognosis in Guillain–Barré Syndrome
por: van Doorn, Pieter A., et al.
Publicado: (2010)

Tracheostomy or Not: Prediction of Prolonged Mechanical Ventilation in Guillain–Barré Syndrome
por: Walgaard, Christa, et al.
Publicado: (2016)

Hospital Admissions, Transfers and Costs of Guillain-Barré Syndrome
por: van Leeuwen, Nikki, et al.
Publicado: (2016)

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, Krista, et al.
Publicado: (2021)

Antibodies to Heteromeric Glycolipid Complexes in Guillain-Barré Syndrome
por: Rinaldi, Simon, et al.
Publicado: (2013)

Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G
por: Fokkink, Willem Jan R., et al.
Publicado: (2015)

Give or take? Intravenous immunoglobulin or plasma exchange for Guillain-Barré syndrome
por: Hughes, Richard AC
Publicado: (2011)

Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome
por: Charra, B, et al.
Publicado: (2009)

Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy
por: Garcia, Jao Jarro, et al.
Publicado: (2021)

Efficient design and analysis of randomized controlled trials in rare neurological diseases: An example in Guillain-Barré syndrome
por: van Leeuwen, Nikki, et al.
Publicado: (2019)

Acute aseptic meningitis due to intravenous immunoglobulin therapy in Guillain–Barré syndrome
por: Jain, Rajendra Singh, et al.
Publicado: (2014)

Changes in motor nerve excitability in acute phase Guillain‐Barré syndrome
por: Drenthen, Judith, et al.
Publicado: (2021)

Prominent Plasmacytosis Following Intravenous Immunoglobulin Correlates with Clinical Improvement in Guillain-Barré Syndrome
por: Mori, Izumi, et al.
Publicado: (2008)

Intravenous Immunoglobulin for Severe Protracted Pediatric Guillain–Barre Syndrome: Is Single Dose Adequate?
por: Madaan, Priyanka, et al.
Publicado: (2019)

Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients
por: van der Zwan, Marieke, et al.
Publicado: (2020)

Small volume plasma exchange for Guillain-Barré syndrome in resource poor settings: a safety and feasibility study
por: Islam, Md. Badrul, et al.
Publicado: (2017)

High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome
por: Thomma, Robin C.M., et al.
Publicado: (2023)

Reversible posterior encephalopathy syndrome due to intravenous immunoglobulin in a child with Guillain-Barré syndrome
por: Incecik, Faruk, et al.
Publicado: (2011)

Intravenous immunoglobulin vs plasma exchange in treatment of mechanically ventilated adults with Guillain-Barré syndrome
por: Charra, Boubaker, et al.
Publicado: (2014)

Intravenous Immunoglobulin may Reverse Multisystem Inflammation in COVID-19 Pneumonitis and Guillain–Barré Syndrome
por: Chakraborty, Nilanchal, et al.
Publicado: (2020)

Guillain-Barré syndrome in times of pandemics
por: Leonhard, Sonja E, et al.
Publicado: (2020)

Diagnosis and management of Guillain–Barré syndrome in ten steps
por: Leonhard, Sonja E., et al.
Publicado: (2019)

Neurofilament light chain as biomarker for axonal damage in Guillain-Barré syndrome
por: Jacobs, Bart C
Publicado: (2021)

Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome
por: Rajabally, Yusuf A.
Publicado: (2022)

Treatment related fluctuation and response to intravenous immunoglobulin therapy in post COVID-19 Guillain-Barre syndrome()
por: Gupta, Subhadeep, et al.
Publicado: (2021)

Intravenous immunoglobulin treatment with prognosis for the first six months of Guillain–Barré Syndrome in Somalia: Case series
por: Sidow, Nor Osman, et al.
Publicado: (2022)

Campylobacter jejuni HS:23 and Guillain-Barré Syndrome, Bangladesh
por: Islam, Zhahirul, et al.
Publicado: (2009)

Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, K., et al.
Publicado: (2020)

High Incidence of Guillain-Barré Syndrome in Children, Bangladesh
por: Islam, Zhahirul, et al.
Publicado: (2011)

Reply to: Comment on: Zika virus and Guillain–Barré syndrome in Bangladesh
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2018)

Diagnosis of Guillain–Barré syndrome in children and validation of the Brighton criteria
por: Roodbol, Joyce, et al.
Publicado: (2017)

Small volume plasma exchange for Guillain-Barré syndrome in resource-limited settings: a phase II safety and feasibility study
por: Islam, Badrul, et al.
Publicado: (2018)

Fatigue in neuromuscular disorders: focus on Guillain–Barré syndrome and Pompe disease
por: de Vries, J. M., et al.
Publicado: (2009)

Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS
por: Fokkink, Willem‐Jan R., et al.
Publicado: (2016)

Zika virus and Guillain–Barré syndrome in Bangladesh
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2018)

Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study
por: El-Bayoumi, Mohammed A, et al.
Publicado: (2011)

Host Factors Determine Anti-GM1 Response Following Oral Challenge of Chickens with Guillain-Barré Syndrome Derived Campylobacter jejuni Strain GB11
por: Ang, C. Wim, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ng57c943747n44k2mridvcba3r